Division Highlights - Allergy, Immunology & Rheumatology

The Division of Allergy, Immunology, and Rheumatology provides state-of-the-art, evidence-based care for children with asthma, allergies, immunologic disorders and rheumatologic diseases.

Our basic and clinical research projects are designed to better understand and find more effective treatments for these diseases.

2016 Highlights

  • James Gern, MD, is the principal investigator on a new, two-year, National Institutes of Health-funded grant to establish the Children’s Respiratory Research and Environment Workgroup. This national consortium of 14 institutions will study how genetics interact with environmental exposures during the prenatal and early childhood years to cause specific subtypes of childhood asthma.

    Dr. Gern also received a supplement to his U19 grant from the National Institutes of Health, National Institute of Allergy and Infectious Diseases Asthma and Allergic Diseases Cooperative Research Centers. The $143,009 supplement supports his project, "A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV-16) Inoculum in Healthy Volunteers."

  • Christopher Healy, MD, received a UW Health Patient Experience Physician Champion Award, which recognizes his exemplary communication skills, empathy and support, as appraised by patients through survey feedback.

  • Anna Huttenlocher, MD, received a five-year, $2.9 million Maximizing Investigators' Research Award (R35) from the National Institutes of Health/National Institute of General Medical Sciences (NIH-NIGMS) for her research project, "Cell Migration and Wound Repair."

  • Daniel Jackson, MD, (PI) and Robert Lemanske, MD, (co-I) received funding along with researchers from the University of Arizona Health Sciences and seven other institutions for a five-year, $27 million cooperative agreement grant from the National Institutes of Health/National Heart, Lung, and Blood Institute (NIH-NHLBI), for their project, "Oral Bacterial Extracts (ORBEX): Primary Prevention of Asthma and Wheezing in Children." The UW's subcontract for ORBEX is for a total of over $2 million.

    Dr. Jackson also received funding for a consortium led by Children's Hospital of Boston. The group will initiate an asthma prevention study entitled "Controlling and Preventing Asthma Severity in Kids" (CASK). The study will determine whether omalizumab (anti-IgE) therapy given to two- and three-year-old children at high risk for asthma based upon having allergies and wheezing will prevent the progression to childhood asthma. This seven-year, U01 grant funded by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID), includes a subcontract to UW-Madison totaling over $2 million.

  • Sujani Kakumanu, MD, FAAAAI, and Robert Lemanske, MD, FAAAAI, collaborated with the American Academy of Allergy, Asthma & Immunology to launch the School-Based Asthma Management Program toolkit, which aims to integrate schools, and specifically school nurses, within a child’s asthma care team.

  • Kathleen Shanovich, NP, and collaborators from the American Family Children’s Hospital Asthma Advocacy Program, the Madison Metropolitan School District, and the Department of Pediatrics received an 11-month, $9,995 mini-grant from the Wisconsin Asthma Coalition for the project, "Comprehensive Asthma Control Through Evidence-Based Strategies and Public Health-Health Care Collaboration."

  • Judith Smith, MD, PhD, received a one-year, $75,460 award from the UW Office of the Vice Chancellor for Research and Graduate Education for her project, "Immunogenetics of Axial Spondyloarthritis.”

    Dr. Smith is also a co-investigator/sub-award principal investigator on a grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases to the Foundation for Research Development in Belo Horizonte, Brazil. Sergio Costa Oliveira, DVM, PhD, from the Federal University of Minas Gerais, is the principal investigator on the five-year R01, "Brucella Survival Strategy Requires Endoplasmic Reticulum Restructuring and Interferes with Innate Immunity."




Recent Publications

Grant Support